Compare M&T Bank Corporation (MTB) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Novavax Inc — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: M&T Bank Corporation is far larger — about 27.8× Novavax Inc's market cap, and M&T Bank Corporation pays a 2.41% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| MTB | NVAX | |
|---|---|---|
Market Cap | $36.15B | $1.30B |
Sector | Financials | Health |
52-Week High | $254.04 | $11.19 |
52-Week Low | $178.63 | $6.22 |
Dividend Yield | 2.41% | — |
Enterprise Value | — | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
